The high expression of BCAM antibody in ovarian carcinomas is not significantly associated with prognosis and is nearly mutually exclusive with PD-L1, which is infrequently expressed, or expressed at relatively low levels in ovarian carcinomas. This evidence concerns the gene BCAM and ovarian carcinoma.